Thorne Healthtech Inc (THRN) Return on Equity ROE from the second quarter 2023 to second quarter 2022 and annually, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Thorne Healthtech Inc   (NASDAQ: THRN)

Thorne Healthtech Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Thorne Healthtech Inc in the second quarter 2023?
Thorne Healthtech Inc achieved a return on average equity (ROE) of 13.58 % in its second quarter 2023 a new company high.

ROE has advanced compared to 7.01% in the first quarter 2023, due to net income growth.

Within the Major Pharmaceutical Preparations industry 39 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1124, from total ROE ranking in the first quarter 2023 at 1727.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Equity Change 24.12 % 16.53 % 23.93 % 16.15 % -
Y / Y Net Income Change - - 715.5 % 277.24 % -
Net Income (TTM) in Millions 20 10 15 4 1
Return On Equity (TTM) 13.58 % 7.01 % 11.24 % 3.22 % 1.17 %
THRN's Total Ranking # 1124 # 1727 # 1469 # 2084 # 0
Equity (TTM) in Millions 155 149 147 132 125
Seq. Equity Change 4.24 % 1.56 % 11.16 % 5.46 % -2.13 %
Seq. Net Income Change - - 245.75 % - -

Back to THRN Management Effectiveness >> THRN's 5 Years Annual ROE >> Compare THRN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 40
Sector # 92
Overall # 1124

Return On Equity Statistics
High Average Low
13.58 %
6.84 %
-0.87 %
  (Jun 30 2022)





THRN Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021


Total Equity in Millions 147 118 0 0 0
Y / Y Equity Change 23.93 % - - - -
Net Income in Millions 15 7 0 0 0
Y / Y Net Income Change 118.16 % - - - -
Return On Equity 10.18 % 5.78 % - - -

Back to THRN Management Effectiveness >> THRN's 5 Years Annual ROE >> Compare THRN ROE to its Competitors




Annual Roe Comment
In 2022 ROE improved to 10.18 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
THRN's' Return on Equity at Yahoo Finance
THRN's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for THRN's Competitors
Subscribers only: Roe for Thorne Healthtech Inc 's Suppliers
Subscribers only: Return On Equity for THRN's Customers




Companies with similar Return On Equity at Jun 30 2023, within Healthcare Sector ROE
Catalyst Pharmaceuticals Inc   36.13 %
Tenax Therapeutics Inc   35.84 %
Exicure Inc   34.49 %
Innoviva Inc   33.94 %
Pro dex Inc   33.92 %
Denali Therapeutics Inc   32.16 %
Arcturus Therapeutics Holdings Inc   31.17 %
Semler Scientific inc   30.26 %
Escalon Medical Corp   28.97 %
Bruker Corporation  28.47 %
Chemed Corporation  27.03 %
Zynex inc   26.71 %
Gilead Sciences Inc   25.83 %
Bristol myers Squibb Company  24.97 %
Resmed Inc   24.17 %
Carlisle Companies Incorporated  23.86 %
Vertex Pharmaceuticals Inc  23.68 %
Viskase Holdings inc   23.34 %
Point Biopharma Global Inc   22.69 %
Edwards Lifesciences Corporation  22.63 %
Encompass Health Corporation  22.19 %
Pfizer Inc  22.11 %
Iradimed Corporation  21.22 %
Agilent Technologies inc   20.65 %
Ufp Technologies Inc   20.45 %
Dynavax Technologies Corporation  19.86 %
Maravai Lifesciences Holdings Inc   19.61 %
Biogen Inc   19.60 %
Corcept Therapeutics Inc  19.57 %
Patterson Companies Inc   19.52 %

Date modified: 2026-08-29T17:45:27+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.